EcoDrugPlus

Coagulation Factor Vii-Like

Ensembl ID : ENSLOCG00000009761
Gene Symbol: LOC102690701
3 Cross references
78 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSLOCG00000009779
Gene Symbol: LOC102691106
3 Cross references
240 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSLOCG00000006632
Gene Symbol: CCDC6
3 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSLOCG00000011078
Gene Symbol: CSF1R
3 Cross references
206 Possible Orthologues:

Complement C5

Ensembl ID : ENSLOCG00000005479
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Complement Component 1, S Subcomponent .2

Ensembl ID : ENSLOCG00000007599
Gene Symbol: C1S.2
1 Cross references
186 Possible Orthologues:

Complement Component 1, S Subcomponent .2

Ensembl ID : ENSLOCG00000007589
Gene Symbol: C1S.2
1 Cross references
186 Possible Orthologues:

Complement Factor D-Like

Ensembl ID : ENSLOCG00000005116
Gene Symbol: LOC102685416
3 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSLOCG00000013245
Gene Symbol: CRHR1
3 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSLOCG00000005067
Gene Symbol: CCND1
3 Cross references
206 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSLOCG00000006690
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSLOCG00000003932
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).